Abstract
Although pneumonia has been a hallmark of Mycoplasma pneumoniae infection, it has been revealed that this infection can cause a number of extrapulmonary manifestations in the absence of pneumonia. While the host immune response has been implicated in the pathomechanism of pneumonia, the pathomechanisms of extrapulmonary manifestations remain largely unknown. It is proposed in this review that extrapulmonary manifestations due to M. pneumoniae infection can be classified into three categories; the first is a direct type in which inflammatory cytokines locally induced by lipoproteins contained in the bacterial cell membrane must play a role, the second is an indirect type in which immune modulation such as autoimmunity through cross-reaction between the bacterial cell components and human cells must play a role, and the third is a vascular occlusion type in which vasculitis and/or thrombosis with or without systemic hypercoagulable state induced by the bacterium must play a role. Based on this classification, a literature review was carried out for extrapulmonary manifestations due to M. pneumoniae infection with special reference to pneumonia, including cardiovascular, dermatological, digestive organ, hematological/hematopoietic system, musculoskeletal, sensory organ, and urogenital tract manifestations. Consequently, most extrapulmonary manifestations due to M. pneumoniae infection can be reasonably classified into and explained by one of the three types of pathomechanisms mentioned above. Noticeably in this review, Kawasaki disease and infectious mononucleosis in association with M. pneumoniae infection, which are not unusual in Japan but have seldom been reported from Western countries, are included in the panel of extrapulmonary manifestations due to M. pneumoniae infection.
Similar content being viewed by others
References
Narita M. Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection. Pediatr Neurol. 2009;41:159–66.
Martire B, Foti C, Cassano N, Buquicchio R, Del Vecchio GC, De Mattia D. Persistent B-cell lymphopenia, multiorgan disease, and erythema multiforme caused by Mycoplasma pneumoniae infection. Pediatr Dermatol. 2005;22:558–60.
Kountouras D, Deutsch M, Emmanuel T, Georgiadis G, Koskinas J. Fulminant Mycoplasma pneumoniae infection with multi-organ involvement: a case report. Eur J Int Med. 2003;14:329–31.
Daxböck F, Brunner G, Popper H, Krause R, Schmid K, Krejs GJ, et al. A case of lung transplantation following Mycoplasma pneumoniae infection. Eur J Clin Microbiol Infect Dis. 2002;21:318–22.
Koletsky RJ, Weinstein AJ. Fulminant Mycoplasma pneumoniae infection. Am Rev Respir Dis. 1980;122:491–6.
Pönkä A. Carditis associated with Mycoplasma pneumoniae infection. Acta Med Scand. 1979;206:77–86.
Sands MJ Jr, Satz JE, Turner WE Jr, Soloff LA. Pericarditis and perimyocarditis associated with active Mycoplasma pneumoniae infection. Ann Intern Med. 1977;86:544–8.
Maresh H, Klimek JJ, Quintiliani R. Myocardial dysfunction and hemolytic anemia in a patient with Mycoplasma pneumoniae infection. Chest. 1977;71:410–3.
Chergui K, Fourme T, Veillard-Baron A, Loubieres Y, Voyer C, Jardin F. Mycoplasma pneumoniae and second-degree heart block. Clin Infect Dis. 1998;27:1534–5.
Umemoto M, Fujii I, Take H. Advanced atrioventricular block associated with atrial tachycardia caused by Mycoplasma pneumoniae infection. Acta Paediatr Jpn. 1995;37:518–20.
Meseguer MA, Pérez-Molina JA, Fernández-Bustamante J, Gómez R, Martos I, Quero MC. Mycoplasma pneumoniae pericarditis and cardiac tamponade in a ten-year-old girl. Pediatr Infect Dis J. 1996;15:829–31.
Kenny RT, Li JS, Clyde WA Jr, Wall TC, O’Connor CM, Campbell PT, et al. Mycoplasmal pericarditis: evidence of invasive disease. Clin Infect Dis. 1993;17(Suppl 1):S58–62.
Naftalin JM, Wellisch G, Kahana Z, Diengott D. Mycoplasma pneumoniae septicemia. J Am Med Assoc. 1974;228:565.
Szymanski M, Petric M, Saunders FE, Tellier R. Mycoplasma pneumoniae pericarditis demonstrated by polymerase chain reaction and electron microscopy. Clin Infect Dis. 2002;34:e16–7.
Scapini JP, Flynn LP, Sciacaluga S, Morales L, Cadario ME. Confirmed Mycoplasma pneumoniae endocarditis. Emerg Infect Dis. 2008;14:1664–5.
Farraj RS, McCully RB, Oh JK, Smith TF. Mycoplasma-associated pericarditis. Mayo Clin Proc. 1997;72:33–6.
Leen C, Ling S. Mycoplasma infection and Kawasaki disease. Arch Dis Child. 1996;75:266–7.
Sakai R, Sakaguchi S, Oguchi S, et al. Three cases of Kawasaki disease complicated by Mycoplasma pneumoniae infection. Shonika Rinsyo. 2007;60:1591–6. (Japanese with English abstract).
Wang JN, Wang SM, Liu CC, Wu JM. Mycoplasma pneumoniae infection associated with Kawasaki disease. Acta Paediatr. 2001;90:594–5.
Narita M, Yamada S, Nakayama T, Sawada H, Nakajima M, Sageshima S. Two cases of lymphadenopathy with liver dysfunction due to Mycoplasma pneumoniae infection with mycoplasmal bacteraemia without pneumonia. J Infect. 2001;42:154–6.
Pinna GS, Kafetzis DA, Tselkas OI, Skevaki CL. Kawasaki disease: an overview. Curr Opin Infect Dis. 2008;21:263–70.
Cherry JD. Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin Infect Dis. 1993;17(Suppl 1):S47–51.
Schalock PC, Dinulos JGH, Pace N, Schwarzenberger K, Wenger JK. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol. 2006;23:546–55.
Léauté-Labrèze C, Lamireau T, Chawki D, Maleville J, Taïeb A. Diagnosis, classification, and management of erythema multiforme and Stevens–Johnson syndrome. Arch Dis Child. 2000;83:347–52.
Tay Y-K, Huff JC, Weston WL. Mycoplasma pneumoniae infection is associated with Stevens–Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol. 1996;35:757–60.
Schalock PC, Dinulos JGH. Mycoplasma pneumoniae-induced cutaneous disease. Int J Dermatol. 2009;48:673–81.
Meseguer MA, de Rafael L, Vidal ML. Stevens–Johnson syndrome with isolation of Mycoplasma pneumoniae from skin lesions. Eur J Clin Microbiol. 1986;5:167–8.
Lyell A, Gordon AM, Dick HM, Sommerville RG. Mycoplasmas and erythema multiforme. Lancet. 1967;ii:1116–8.
Mulvey JM, Padowitz A, Lindley-Jones M, Nickels R. Mycoplasma pneumoniae associated with Stevens Johnson syndrome. Anaesth Intensive Care. 2007;35:414–7.
Biberfeld G. Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol. 1971;8:319–33.
Brunner H, Prescott B, Greenberg H, James WD, Horswood RL, Chanock RM. Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques. J Infect Dis. 1977;135:524–30.
Kano Y, Mitsuyama Y, Hirahara K, Shiohara T. Mycoplasma pneumoniae infection-induced erythema nodosum, anaphylactoid purpura, and acute urticaria in 3 people in a single family. J Am Acad Dermatol. 2007;57(2 Suppl):S33–5.
Ghosh K, Clements GB. Surveillance of Mycoplasma pneumoniae infections in Scotland 1986–1991. J Infect. 1992;25:221–7.
Romero-Gómez M, Otero MA, Sánchez-Muñoz D, Ramírez-Arcos M, Larraona JL, García ES, et al. Acute hepatitis due to Mycoplasma pneumoniae infection without lung involvement in adult patients. J Hepatol. 2006;44:827–8.
Daxboeck F, Gattringer R, Mustafa S, Bauer C, Assadian O. Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia. Clin Microbiol Infect. 2005;11:507–10.
Grüllich C, Baumert TF, Blum HE. Acute Mycoplasma pneumoniae infection presenting as cholestatic hepatitis. J Clin Microbiol. 2003;41:514–5.
Suzuyama Y, Iwasaki H, Izumikawa K, Hara K. Clinical complications of Mycoplasma pneumoniae disease. Other organs. Yale J Biol Med. 1983;56:487–91.
Quioc JJ, Trabut JB, Drouhin F, Malbrunot C, Vallet-Pichard A, Pol S, et al. Acute cholestatic hepatitis revealing Mycoplasma pneumoniae infection without lung involvement in an adult patient. Eur J Gastroenterol Hepatol. 2009;21:220–1.
Nagayama Y, Sakurai N, Yamamoto K. Clinical observations of children with pleuropneumonia due to Mycoplasma pneumoniae. Pediatr Pulmonol. 1990;8:182–7.
Van Bever HP, Van Doorn JWD, Demey HE. Adult respiratory distress syndrome associated with Mycoplasma pneumoniae infection. Eur J Pediatr. 1992;151:227–8.
Oderda G, Kraut JR. Rising antibody titer to Mycoplasma pneumoniae in acute pancreatitis. Pediatrics. 1980;60:305–6.
Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697–728.
Feizi T, Loveless RW. Carbohydrate recognition by Mycoplasma pneumoniae and pathologic consequences. Am J Respir Crit Care Med. 1996;154:5133–6.
Cassell GH, Cole BC. Mycoplasmas as agents of human disease. N Engl J Med. 1981;304:80–7.
Ishida Y, Hiroi K, Tauchi H, Oto Y, Tokuda K, Kida K. Hemophagocytic lymphohistiocytosis secondary to Mycoplasma pneumoniae infection. Pediatr Int. 2004;46:174–7.
Mizukane R, Kadota J, Yamaguchi T, Kiya T, Fukushima H, Nakatomi M, et al. An elderly patients with hemophagocytic syndrome due to severe Mycoplasma pneumonia with marked hypercytokinemia. Respiration. 2002;69:87–91.
Bruch LA, Jefferson RJ, Pike MG, Gould SJ, Squier W. Mycoplasma pneumoniae infection, meningoencephalitis, and hemophagocytosis. Pediatr Neurol. 2001;25:67–70.
Chyrssanthopoulos C, Eboriadou M, Monti K, Soubassi V, Sava K. Fatal disseminated intravascular coagulation caused by Mycoplasma pneumoniae. Pediatr Infect Dis J. 2001;20:634–5.
Chiou C-C, Liu Y-C, Lin H-H, Hsieh K-S. Mycoplasma pneumoniae infection complicated by lung abscess, pleural effusion, thrombocytopenia and disseminated intravascular coagulation. Pediatr Infect Dis J. 1997;16:327–9.
Fumarola D. Intravascular coagulation and Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 1997;16:1012–3. (Letter to ref. 49).
De Vos M, Van Nimmen L, Baele G. Disseminated intravascular coagulation during a fatal Mycoplasma pneumoniae infection. Acta Haematol. 1974;52:120–5.
Nilsson IM, Rausing A, Denneberg T, Christensson P. Intravascular coagulation and acute renal failure in a child with mycoplasma infection. Acta Med Scand. 1971;189:359–65.
Meir EB, Amital H, Levy Y, Kneller A, Bar-Dayan Y, Schoenfeld Y. Mycoplasma-pneumoniae-induced thrombotic thrombocytopenic purpura. Acta Haematol. 2000;103:112–5.
Okoli K, Gupta A, Irani F, Kasmani R. Immune thrombocytopenia associated with Mycoplasma pneumoniae infection: a case report and review of literature. Blood Coagul Fibrinolysis. 2009; doi:10.1097/MBC.0b013e32832d6ccb.
Ono T, Yoshida N, Miyazaki S, Hirose M. Infectious mononucleosis-like syndrome associated with Mycoplasma infection. Jpn J Jpn Pediatr Soc. 1991;95:132–6. (Japanese with English abstract).
Witmer CM, Steenhoff AP, Shah SS, Raffini LJ. Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association? Pediatrics. 2007;119:e292–5.
Graw-Panzer KD, Verma S, Rao S, Miller ST, Lee H. Venous thrombosis and pulmonary embolism in a child with pneumonia due to Mycoplasma pneumoniae. J Natl Med Assoc. 2009;101:956–8.
Snowden N, Wilson PB, Longson M, Pumphrey RSH. Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad Med J. 1990;66:356–62.
Franz A, Webster ADB, Furr PM, Taylor-Robison D. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol. 1997;36:661–8.
Taylor-Robinson D, Gumpel JM, Hill A, Swannell AJ. Isolation of Mycoplasma pneumoniae from the synovial fluid of a hypogammaglobulinaemic patient in a survey of patients with inflammatory polyarthritis. Ann Rheum Dis. 1978;37:180–2.
O’Sullivan MVN, Isbel NM, Johnson DW, Rencken K, Byrne S, Graham MM, et al. Disseminated pyogenic Mycoplasma pneumoniae infection in a renal transplant recipient, detected by broad-range polymerase chain reaction. Clin Infect Dis. 2004;39:e98–9.
Davis CP, Cochran S, Lisse J, Buck G, DiNuzzo AR, Weber T, et al. Isolation of Mycoplasma pneumoniae from synovial fluid samples in a patient with pneumonia and polyarthritis. Arch Intern Med. 1988;148:969–70.
Chaudhry R, Nisar N, Malhotra P, Kumar A, Chauhan VS. Polymerase chain reaction confirmed Mycoplasma pneumoniae arthritis: a case report. Indian J Pathol Microbiol. 2003;46:433–6.
Azumagawa K, Kambara Y, Murata T, Tamai H. Four cases of arthritis associated with Mycoplasma pneumoniae infection. Pediatr Int. 2008;50:511–3.
Weng W-C, Peng SS-F, Wang SB, Chou Y-T, Lee W-T. Mycoplasma pneumoniae-associated transverse myelitis and rhabdomyolysis. Pediatr Neurol. 2009;40:128–30.
Minami K, Maeda H, Yanagawa T, Suzuki H, Izumi G, Yoshikawa N. Rhabdomyolysis associated with Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 2003;22:291–3.
Berger RP, Wadowksy RM. Rhabdomyolysis associated with infection by Mycoplasma pneumoniae: a case report. Pediatrics. 2000;105:433–6.
Decaux G, Szyper M, Ectors M, Cornil A, Franken L. Central nervous system complications of Mycoplasma pneumoniae. J Neurol Neurosurg Psychiatry. 1980;43:883–7.
Rothstein TL, Kenny GE. Cranial neuropathy, myeloradiculopathy, and myositis. Complications of Mycoplasma pneumoniae infection. Arch Neurol. 1979;36:476–7.
Waites KB, Atkinson TP. The role of Mycoplasma in upper respiratory infections. Curr Infect Dis Rep. 2009;11:198–206.
Sobĕslavský O, Syrůček L, Brůčková M, Abrahamovič M. The etiological role of Mycoplasma pneumoniae in otitis media in children. Pediatrics. 1965;35:652–7.
Räty R, Kleemola M. Detection of Mycoplasma pneumoniae by polymerase chain reaction in middle ear fluids from infants with acute otitis media. Pediatr Infect Dis J. 2000;19:666–8.
García Berrocal JR, Ramírez-Camacho R, Portero F, Vargas JA. Role of viral and Mycoplasma pneumoniae infection in idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2000;120:835–9.
Salzman MB, Sood SK, Slavin ML, Rubin LG. Ocular manifestations of Mycoplasma pneumoniae infection. Clin Infect Dis. 1992;14:1137–9.
Weinstein O, Shneck M, Levy J, Lifsbitz T. Bilateral acute anterior uveitis as a presenting symptom of Mycoplasma pneumoniae infection. Can J Ophthalmol. 2006;41:594–5.
Sánchez-Vargas FM, Gómez-Duarte OG. Mycoplasma pneumoniae––an emerging extra-pulmonary pathogen. Clin Microbiol Infect. 2008;14:105–15.
Siomou E, Kollios KD, Papadimitriou P, Kostoula A, Papadopoulou ZL. Acute nephritis and respiratory tract infection caused by Mycoplasma pneumoniae: case report and review of the literature. Pediatr Infect Dis J. 2003;22:1103–6.
Said MH, Layani MP, Colon S, Faraj G, Glastre C, Cochat P. Mycoplasma pneumoniae-associated nephritis in children. Pediatr Nephrol. 1999;13:39–44.
Suzuki K, Hirano K, Onodera N, Takahashi T, Tanaka H. Acute IgA nephropathy associated with Mycoplasma pneumoniae infection. Pediatr Int. 2005;47:583–5.
Mizutani H, Mizutani H. Circulating immune complexes in patients with mycoplasmal pneumonia. Am Rev Respir Dis. 1984;130:627–9.
Biberfeld G, Norberg R. Circulating immune complexes in Mycoplasma pneumoniae infection. J Immunol. 1974;112:413–5.
Hirshberg SJ, Charles RS, Ettinger JB. Pediatric priapism associated with Mycoplasma pneumoniae. Urology. 1996;47:745–6.
Tagliabue C, Salvatore CM, Techasaensiri C, Mejias A, Torres JP, Katz K, et al. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. J Infect Dis. 2008;198:1180–8.
Amsden GW. Anti-inflammatory effects of macrolides––an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother. 2005;55:10–21.
Barile MF, Kapatais-Zoumbos K, Snoy P, Grabowski MW, Sneller M, Miller L, et al. Experimentally induced septic arthritis in chimpanzees infected with Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum. Clin Infect Dis. 1994;18:694–703.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Narita, M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother 16, 162–169 (2010). https://doi.org/10.1007/s10156-010-0044-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10156-010-0044-x